Impella Controller Recall; AI-Enabled Risk Tool; BP Control and Retina Changes

(MedPage Today) — The issue of faulty Automated Impella Controllers was elevated to a class I recall by the FDA, following five serious injuries.
The agency also revised the label for fenofibrates to remove language about cardiovascular benefits…